Interim Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($) $ in Thousands |
Share capital |
Share Premium |
Capital reserve from share -based payment transactions |
Warrants exercisable into shares |
Treasury shares |
Accumulated other comprehensive income |
Accumulated deficit |
Total |
Non-controlling interests |
Total |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Dec. 31, 2015 | $ 1,780 | $ 79,864 | $ 4,864 | $ 6,947 | $ (970) | $ 232 | $ (78,966) | $ 13,751 | $ 175 | $ 13,926 |
| Net loss | (8,257) | (8,257) | (136) | (8,393) | ||||||
| Loss from defined benefit plans | 140 | (140) | ||||||||
| Adjustment arising from translating financial statements from functional currency to presentation currency | 119 | 119 | 119 | |||||||
| Total comprehensive loss | 259 | (8,397) | (8,138) | (136) | (8,274) | |||||
| Share-based payments | 3 | 303 | 306 | 3 | 309 | |||||
| Balance at Dec. 31, 2016 | 1,783 | 79,864 | 5,167 | 6,947 | (970) | 491 | (87,363) | 5,919 | 42 | 5,961 |
| Net loss | (6,339) | (6,339) | (94) | (6,433) | ||||||
| Adjustment arising from translating financial statements from functional currency to presentation currency | 636 | 636 | 636 | |||||||
| Total comprehensive loss | 636 | (6,339) | (5,703) | (94) | (5,797) | |||||
| Issuance of share capital and warrants, net of issue expenses | 330 | 1,993 | 188 | 1,868 | 4,379 | 4,379 | ||||
| Issuance of share capital | 10 | 85 | 95 | 95 | ||||||
| Proceeds from sale of subsidiary in previously consolidated subsidiaries | (838) | 970 | 132 | 52 | 184 | |||||
| Share-based payments | 192 | 192 | 192 | |||||||
| Balance at Dec. 31, 2017 | 2,123 | 81,104 | 5,547 | 8,815 | 1,127 | (93,702) | 5,014 | 5,014 | ||
| Net loss | (2,965) | 2,965 | ||||||||
| IAS 18 to IFRS 15 implementation | (350) | (350) | ||||||||
| Issuance of share capital and warrants, net of issue expenses | 482 | 3,905 | 4,387 | |||||||
| Issuance of share capital | 28 | 230 | 258 | |||||||
| Share-based payments | 166 | 166 | ||||||||
| Balance at Jun. 30, 2018 | 2,633 | 94,054 | 5,713 | (95,890) | 6,510 | |||||
| Balance at Dec. 31, 2017 | 2,123 | 81,104 | 5,547 | 8,815 | 1,127 | (93,702) | 5,014 | 5,014 | ||
| Net loss | (6,571) | (6,571) | (6,571) | |||||||
| Cumulative effect of initial adoption of IFRS 15 as of January 1, 2018 (see Note 4) | (350) | (350) | (350) | |||||||
| Total comprehensive loss | (6,571) | |||||||||
| Issuance of share capital and warrants, net of issue expenses | 482 | 312 | 3,593 | 4,387 | 4,387 | |||||
| Issuance of share capital | 30 | 252 | 282 | 282 | ||||||
| Share-based payments | 253 | 253 | 253 | |||||||
| Balance at Dec. 31, 2018 | 2,635 | 81,668 | 5,800 | 12,408 | 1,127 | (100,623) | 3,287 | 3,015 | ||
| Net loss | (4,893) | 4,893 | ||||||||
| Issuance of share capital and warrants, net of issue expenses | 4,112 | 6,056 | 10,168 | |||||||
| Share-based payments | 151 | 151 | ||||||||
| Balance at Jun. 30, 2019 | 6,747 | 100,132 | 5,951 | 1,127 | (105,516) | 8,441 | ||||
| Balance at Dec. 31, 2018 | $ 2,635 | $ 81,668 | $ 5,800 | $ 12,408 | $ 1,127 | $ (100,623) | $ 3,287 | 3,015 | ||
| Net loss | 7,841 | |||||||||
| Balance at Sep. 30, 2019 | $ 7,056 |